Technology · 10/16/2026
Aignostics Introduces HETA Clinical, a New Family of Cancer-Agnostic AI Products
Aignostics has announced the market launch of HETA Clinical, a new family of cancer-agnostic AI products that accelerate workflows in pathology and reduce the number of failed molecular tests.
Original source language: PR NewswireOpen original release →